Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanisław Surma

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Current Atherosclerosis Reports|January 2, 2024
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?Stanisław Surma, Amirhossein Sahebkar, Maciej Banach
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|November 1, 2020
Natriuretic peptides in diagnostics and therapyMonika Romańczyk, STANISłAW Surma, Krzysztof Łabuzek
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering TherapyBożena Sosnowska, Stanisław Surma, Maciej Banach
Pharmacological Research|December 6, 2022
Coffee or tea: Anti-inflammatory properties in the context of atherosclerotic cardiovascular disease preventionStanisław Surma, Amirhossein Sahebkar, Maciej Banach
European Journal of Preventive Cardiology|October 8, 2025
Periodontitis and Atrial FibrillationStanisław Surma, Gregory Y H Lip
Lipids in Health and Disease|October 25, 2021
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infectionStanisław Surma, Maciej Banach, Joanna Lewek
Current Hypertension Reports|April 22, 2022
Pet Ownership and the Risk of Arterial Hypertension and Cardiovascular DiseaseStanisław Surma, Suzanne Oparil, Krzysztof Narkiewicz
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|January 25, 2022
Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatmentMarcin Adamczak, Stanisław Surma, Andrzej Więcek
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|June 22, 2020
Coronavirus SARS-Cov-2 and arterial hypertension - facts and mythsStanisŁaw Surma, Monika Romańczyk, Krzysztof Łabuzek
Archives of Medical Science : AMS|December 7, 2023
2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?Maciej Banach, Stanisław Surma, Peter P Toth, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Current Atherosclerosis Reports|January 2, 2024
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?Stanisław Surma, Amirhossein Sahebkar, Maciej Banach
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|November 1, 2020
Natriuretic peptides in diagnostics and therapyMonika Romańczyk, STANISłAW Surma, Krzysztof Łabuzek
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering TherapyBożena Sosnowska, Stanisław Surma, Maciej Banach
Pharmacological Research|December 6, 2022
Coffee or tea: Anti-inflammatory properties in the context of atherosclerotic cardiovascular disease preventionStanisław Surma, Amirhossein Sahebkar, Maciej Banach
European Journal of Preventive Cardiology|October 8, 2025
Periodontitis and Atrial FibrillationStanisław Surma, Gregory Y H Lip
Lipids in Health and Disease|October 25, 2021
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infectionStanisław Surma, Maciej Banach, Joanna Lewek
Current Hypertension Reports|April 22, 2022
Pet Ownership and the Risk of Arterial Hypertension and Cardiovascular DiseaseStanisław Surma, Suzanne Oparil, Krzysztof Narkiewicz
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|January 25, 2022
Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatmentMarcin Adamczak, Stanisław Surma, Andrzej Więcek
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|June 22, 2020
Coronavirus SARS-Cov-2 and arterial hypertension - facts and mythsStanisŁaw Surma, Monika Romańczyk, Krzysztof Łabuzek
Archives of Medical Science : AMS|December 7, 2023
2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?Maciej Banach, Stanisław Surma, Peter P Toth, et al.
Pageof 7